相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Targeted deletion of HAI-1 increases prostasin proteolysis but decreases matriptase proteolysis in human keratinocytes
Dajun D. Lu et al.
HUMAN CELL (2021)
Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2
Signe Skovbjerg et al.
BIOCHEMICAL JOURNAL (2020)
Mild acidity likely accelerates the physiological matriptase autoactivation process: a comparative study between spontaneous and acid-induced matriptase zymogen activation
Bailing Jia et al.
HUMAN CELL (2020)
Matriptase drives early-onset intestinal failure in a mouse model of congenital tufting enteropathy
Roman Szabo et al.
DEVELOPMENT (2019)
Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine
Makiko Kawaguchi et al.
COMMUNICATIONS BIOLOGY (2019)
Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): Emerging key players in epithelial integrity and cancer
Hiroaki Kataoka et al.
PATHOLOGY INTERNATIONAL (2018)
Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells
Koji Yamamoto et al.
Oncotarget (2018)
The crystal structure of a multidomain protease inhibitor (HAI-1) reveals the mechanism of its auto-inhibition
Min Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1
Tomohiro Ishikawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
HAI-2 stabilizes, inhibits and regulates SEA-cleavage-dependent secretory transport of matriptase
Annika W. Nonboe et al.
TRAFFIC (2017)
Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity
Chun-Che Tseng et al.
PLOS ONE (2017)
Crystal Structure of a Two-domain Fragment of Hepatocyte Growth Factor Activator Inhibitor-1: FUNCTIONAL INTERACTIONS BETWEEN THE KUNITZ-TYPE INHIBITOR DOMAIN-1 AND THE NEIGHBORING POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN
Zebin Hong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Hepatocyte Growth Factor Activator Inhibitor Type 1 Maintains the Assembly of Keratin into Desmosomes in Keratinocytes by Regulating Protease-Activated Receptor 2-Dependent p38 Signaling
Makiko Kawaguchi et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
The solution structure of the MANEC-type domain from hepatocyte growth factor activator inhibitor-1 reveals an unexpected PAN/apple domain-type fold
Zebin Hong et al.
BIOCHEMICAL JOURNAL (2015)
Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis
Shinri Hoshiko et al.
CANCER RESEARCH (2013)
Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase
Takahiro Domoto et al.
CANCER SCIENCE (2012)
Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis
P. Kosa et al.
ONCOGENE (2012)
Membrane-Bound Serine Protease Inhibitor HAI-1 Is Required for Maintenance of Intestinal Epithelial Integrity
Makiko Kawaguchi et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Membrane-Anchored Serine Proteases in Vertebrate Cell and Developmental Biology
Roman Szabo et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase
R. Szabo et al.
ONCOGENE (2011)
Matriptase Activation, an Early Cellular Response to Acidosis
I-Chu Tseng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Loss of Matriptase Suppression Underlies Spint1 Mutation-Associated Ichthyosis and Postnatal Lethality
Roman Szabo et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Defect of Hepatocyte Growth Factor Activator Inhibitor Type 1/Serine Protease Inhibitor, Kunitz Type 1 (Hai-1/Spint1) Leads to Ichthyosis-Like Condition and Abnormal Hair Development in Mice
Koki Nagaike et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity
Roman Szabo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase
Kenji Kojima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain
Ming-Shyue Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development
R. Szabo et al.
ONCOGENE (2007)
Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis
K List et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Matriptase: Potent proteolysis on the cell surface
Karin List et al.
MOLECULAR MEDICINE (2006)
Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation
K List et al.
GENES & DEVELOPMENT (2005)
HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease
MD Oberst et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta
H Tanaka et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in cancer cells at the invasion front
K Nagaike et al.
CANCER SCIENCE (2004)
Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator Inhibitor-1B (HAI-1B), a new splice variant of HAI-1
D Kirchhofer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Characterization of matriptase expression in normal human tissues
MD Oberst et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2003)
The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor
MD Oberst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Archaeal surface layer proteins contain β propeller, PKD, and β helix domains and are related to metazoan cell surface proteins
H Jing et al.
STRUCTURE (2002)
Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase
C Benaud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
N-terminal processing is essential for release of epithin, a mouse type II membrane serine protease
EG Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo
M Oberst et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor
C Benaud et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment
H Kataoka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)